Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial

Authors: André Lacroix, Feng Gu, Wilson Gallardo, Rosario Pivonello, Yerong Yu, Przemysław Witek, Marco Boscaro, Roberto Salvatori, Masanobu Yamada, Libuse Tauchmanovà, Sy Ha, Shoba Ravichandran, Stephan Petersenn, Beverly M. K. Biller, John Newell‐Price, Giorgio Arnaldi, Hesarghatta Shyamasunder Asha, Tushar Bandgar, Ariel Barkan, Henrik Biering, Marie Bex, Marek Bolanowski, Marcello D. Bronstein, Thierry Brue, Darío Bruera, Francesco Cavagnini, Abdurrahman Çömlekçi, Christophe De Block, Tuncay Delibaşı, Carmen Fajardo, Richard A. Feelders, Maria Fleseriu, Mônica R. Gadelha, Eliza B. Geer, Anthony P. Heaney, Ghislaine Houde, Atsuhiro Ichihara, Syed Ali Imran, Adriana G. Ioachimescu, Pınar Kadıoğlu, Yiming Li, Paola Loli, Mitsuru Nishiyama, Liudmila Rozhinskaya, Marek Ruchała, Youichi Saitoh, Christof Schöfl, Jochen Schopohl, Akira Shimatsu, Chikara Shimizu, Thiti Snabboon, Peter J. Snyder, Noriyuki Suzaki, Antoine Tabarin, Yutaka Takahashi, Susana Tara Britto, Guy T’Sjoen, Marie‐Christine Vantyghem, Brigitte Velkeniers, Susan M. Webb, Shozo Yamada - The Lancet 2017 cited by 165